Centessa Pharmaceuticals plc (CNTA) Tops Q1 EPS by 16c

Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q1 EPS of ($0.20), $0.16 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $15 million versus the consensus estimate of $0 .

For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Franklin Dentist, The Opal Dental Co., Relocates to New Franklin, WI, Marking New Operational Milestone
• Evercore ISI: 'AAPL has so far offset softer App Store trends with faster-growing areas'